Mumps

[unable to retrieve full-text content] What's Going Around: COVID, flu, strep, stomach bug    ABC27

Nika Schoonover - Tuesday, January 3rd, 2023 The following chief medical officer executive moves were reported by Becker's in 2022: Sharileda Vance, MD, was selected to serve as chief medical officer at Parkersburg, W.Va.-based WVU Medicine Camden Clark Medical Center.  Danielle Mahaffey, MD, was selected to serve as chief medical officer at Alamance Regional Medical Center in Burlington, N.C.  Steven Smith, MD, was named chief medical officer at University of Maryland Charles Regional Medical Center in La Plata.  Aaron Kugelmass, MD, was named executive vice president and chief medical officer of Deborah Heart and Lung Center in Brown Mills, N.J.  Carl Sirio, MD, was named chief medical officer at Temple University Health System in Philadelphia.  Susan Kaufman, DO, was named vice president and chief medical officer at Lima (Ohio) Memorial Health System, an affiliate of Toledo, Ohio-based ProMedica.&nb...

(Credit: Morsa Images / Getty Images) Senior living communities are not healthcare settings and should not be regulated as such, Argentum told the federal government Tuesday. In a letter to the Occupational Safety and Health Administration, Argentum President and CEO James Balda argued that senior living communities are "home" to many older adults and provide only limited healthcare services. In addition, assisted living communities are a "lower-risk environment" than hospital and non-hospital ambulatory care settings, which were exempt from OSHA's emergency temporary standard in certain cases, he said. "As such, it is our position that ALFs should not be considered 'healthcare settings' and should not be subject to any further requirements imposed by OSHA's rulemaking," Balda wrote. The CEO sent the letter in response to OSHA's proposed COVID-19 healthcare rule. It's the fifth tim...

Some researchers are thinking outside the box to try to combat the growing antibiotic resistance crisis. One of the innovations has been the development of "living medicines" which use one living bacterium to kill another. In a new study, researchers developed a modified (non-pathogenic) version of Mycoplasma pneumoniae that attacks Pseudomonas aeruginosa— which is resistant to many types of antibiotics and is a common source of infections in hospitals. The modified M. pneumoniae was used in combination with low doses of antibiotics that would otherwise not work on their own. The M. pneumoniae treatment significantly reduced lung infections in mice and doubled mouse survival rate compared to no treatment. Administering a single, high dose of the treatment showed no signs of toxicity in the lungs. And, once the treatment had finished its course, the immune system cleared the modified bacteria in a period of four days. This research is published in Nature Biotech...

DOWNERS GROVE, Ill. , Jan. 23, 2023 /PRNewswire/ -- Univar Solutions Inc. (NYSE: UNVR) ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, announced today that it has signed an agreement to acquire leading Turkish specialty chemicals distributor Kale Kimya. Continue Reading Univar Solutions Acquires Leading Turkish Distributor, Kale Kimya Tweet this Univar Solutions to Expand Beauty and Personal Care, Home and Industrial Cleaning Portfolios with Acquisition of Leading Turkish Distributor, Kale Kimya First established in 1975, Kale Kimya offers best-in-class formulation laboratory capabilities and technical expertise as well as an extensive product portfolio of beauty and personal care products, and home and industrial cleaning products, including surfactants, actives, emulsifiers, preservatives, UV filters, fragrances, ...

The combination of influenza, COVID-19, and respiratory syncytial virus (RSV) is putting severe strain on hospitals in many countries. Although many people who are infected with these viruses will recover without any unexpected trouble, a minority will develop pneumonia and require hospital treatment. Pneumonia is an infection of the lungs that can be caused by viruses, bacteria or fungi. The lungs are made up of tiny sacs called alveoli, which fill with air when we breathe, and move oxygen and carbon dioxide in and out of the bloodstream. Pneumonia causes these air sacs to fill up with pus and fluid, which makes it harder to breathe, and for our organs to get enough oxygen. You should seek immediate medical attention if you experience difficulty breathing, develop a bluish colour in your lips or fingertips, have chest pain, a high fever, or a cough with mucus that is severe or getting worse. People of all ages can develop pneumonia, and their symptoms can vary ...

The B.C.G. vaccine, more than a century old, has shown some promise against diabetes. The university's move left parents and outside investigators concerned. Researchers at N.Y.U. Langone Health have pulled out of a trial investigating the use of an old tuberculosis vaccine to treat children with Type 1 diabetes only months after they began enrolling participants on Long Island. The vaccine, called Bacillus-Calmette-Guerin, or B.C.G., has generated intense interest among various patient advocacy groups, including those focused on Alzheimer's disease and cancer, as well as diabetes. Some recent research suggests that the vaccine, first administered in 1921, also may protect against Covid-19 and respiratory diseases because of its broad effects on the immune system. A large trial of the vaccine's effects on blood sugar in adults with Type 1 diabetes is nearing completion. Scientists had hoped to test the B.C.G. vaccines on children as well, since good management of Type 1 dia...